Azithromycin is an antibiotic used for the treatment of a number of bacterial infections. This includes middle ear infections, strep throat, pneumonia, traveler’s diarrhea, and certain other intestinal infections. It may also be used for a number of sexually transmitted infections, including chlamydia and gonorrhea infections. Along with other medications, it may also be used for malaria. It can be taken by mouth or intravenously with doses once per day.
This report contains market size and forecasts of Azithromycin in global, including the following market information:
Global Azithromycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
– Table of Contents
– List of Tables & Figures
– Charts
– Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-azithromycin-forecast-2022-2028-367
Global Azithromycin Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Azithromycin companies in 2021 (%)
The global Azithromycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Azithromycin include Pfizer, Akorn, Teva, Mylan, Zydus Pharmaceuticals, Sandoz, Wockhardt, Gland Pharma and Aurobindo Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Azithromycin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment: Global Azithromycin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Azithromycin Market Segment Percentages, by Type, 2021 (%)
- Oral
- Injectables
- Ophthalmics
Global Azithromycin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Azithromycin Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Azithromycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Azithromycin Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Azithromycin revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Azithromycin revenues share in global market, 2021 (%)
- Key companies Azithromycin sales in global market, 2017-2022 (Estimated), (Kg)
- Key companies Azithromycin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Akorn
- Teva
- Mylan
- Zydus Pharmaceuticals
- Sandoz
- Wockhardt
- Gland Pharma
- Aurobindo Pharma
- CSPC Ouyi Pharmaceutical
- Hainan Poly Pharm
- Hainan Hailing Chemipharma Corporation
- Anke Hengyi
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
